Navigation Links
Panel Convened at Society of Nuclear Medicine and Molecular Imaging Meeting Say MO-99 Supplies are Secure
Date:6/28/2017

Supplies of the critical medical isotope molybdenum-99 (Mo-99) are secure and reliable according to a panel of leading experts gathered at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2017 annual meeting in Denver, Colorado in June. Mo-99 is the parent isotope of technetium-99m (Tc-99m), which is used in 30 to 40 million nuclear medicine procedures worldwide every year. (1)

Sally Schwarz, President of SNMMI, and Professor of Radiology at the Mallinckrodt Institute of Radiology at the Washington University School of Medicine in St. Louis, moderated the panel. The panel of top executives from Mo-99 producers addressed the specific steps that their companies are taking to ensure that the approximately 100,000 patients who rely on nuclear imaging testing worldwide each day will have access to the diagnostic care they need.

“It’s clear that the world’s Mo-99 producers have collaboratively used innovation, technology and careful planning to increase capacity and safeguard supplies of this critical medical isotope,” said Professor Schwarz.

Panelists included Jayne Senior, General Manager of ANSTO Nuclear Medicine; Frank de Lange, Vice President Manufacturing, Petten and Managing Director of Curium; Jean-Michel Vanderhofstadt, CEO of the Institute for Radio Elements (IRE); and Piet Louw, Executive Manager of NTP Radioisotopes.

Some of the strategies and investments being made to secure a stable and viable supply and market in the future included:

1.    Increased Capacity. Current Mo-99 producers have made significant investments and improvements to increase manufacturing capacity for routine production as well as planned and unplanned outages. These actions ensure the security of supply to the global industry as it more than replaced the capacity lost when the NRU and OSIRIS research reactors ceased production of Mo-99.
2.    Ongoing maintenance and investments. All reactors need routine maintenance and may occasionally experience unexpected shutdowns.    Major producers contract for extra target irradiation positions with their reactor partners (known as Outage Reserve Capacity) to continue to provide supply during an unexpected shutdown. Adequate target irradiation space, whether it is used or not, is paid for by the producers.
3.    Global cooperation. The Association of Imaging Producers and Equipment Suppliers (AIPES) coordinate the international scheduling of reactors that produce Mo-99 to help plan adequate target irradiation capacity and minimize supply risks. This group assembles multiple times each year and maintains ongoing, continuous communications outside of formal meetings to harmonize reactor scheduling. The major Mo-99 producers around the world participate in this initiative to plan for replacement of closed reactors and have coordinated actions to increase capacity to secure the reliable supply of Mo-99 and hence Tc-99M in the future.
“With these safeguards and investments in Mo-99 production, we look forward to offering the nuclear medicine community peace of mind and stability for the future,” concludes Professor Schwarz.

                                                                         # # #

About Curium
Curium is a world-class nuclear medicine solutions provider with more than a century of industry experience. Formed by the merger of IBA Molecular and Mallinckrodt Nuclear Medicine LLC, Curium is the largest vertically integrated radiopharmaceutical product manufacturer in the industry.

With manufacturing facilities across Europe and the United States, Curium supports over 14 million patients around the word with SPECT, PET and therapeutic radiopharmaceuticals to provide potentially life-saving diagnostic solutions. The Curium brand name is inspired by the work of radiation researchers Marie and Pierre Curie and emphasizes a focus on nuclear medicine. To learn more, visit curiumpharma.com.

                                                                             # # #

(1) HLG-MR;2016 Medical IsotopeSupply Review:99Mo/99mTc Market Demand and Production Capacity Projection 2016-2021

Read the full story at http://www.prweb.com/releases/2017/06/prweb14466754.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Asymmetrex Will Join RegMedNet Panel to Discuss New Developments in Regulatory Policies for Stem Cell Medical Research
2. Slone Partners Hosts Precision Medicine Event Led by Michael Pellini, MD with Panelists Troy Cox, Barbara Weber, MD and Roman Yelensky, PhD
3. BIOARRAY Genetics Inc. Announces the Launch of a Novel Oncology Gene Panel
4. BERG Announces BPM 31510 Data Presentations at 2017 AACR in Immuno-Oncology, Glioblastoma Mutiforme, Pancreatic Cancers and Novel Prostate Cancer Biomarker Panel
5. Pertheras Chief Bioinformatics Officer Speaking at The American Medical Informatics Association (AMIA) 2017 Joint Summits Panels
6. AT&T Joins Connect to End Cancer Panel Series at the 2017 SXSW Conference
7. Opal Kelly Announces XEM7010 and XEM7310 with Xilinx Artix-7 and FrontPanel SDK
8. ZeptoMetrix™ and FIND Announce New Culture Panels to Develop High Sensitivity Malaria Test
9. Opal Kelly Announces ZEM5310 with Altera Cyclone V E and FrontPanel SDK
10. Connect with DrugDev at the SCOPE Summit for Clinical Operations Executives for Engaging Customer-Led Panel Discussions and the Anticipated Reveal of DrugDev Spark™
11. OGT veröffentlicht gezieltes NGS-Panel zur Untersuchung von SNV und CNV bei familiärer Hypercholesterinämie
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2019)... ... 22, 2019 , ... Dr. Douglas Stramel of Advanced Care Veterinary Services ... System (V-PET™) for nearly three years. A proponent of Regenerative Medicine, Dr. ... and began using V-PET™ 2016. V-PET™ is a gravity filtration-based platelet therapy kit ...
(Date:1/20/2019)... ... 2019 , ... Consumers are directing healthcare in many ways, ... changing as many services now exist for patients to order tests without a ... million in 2018, according to Kalorama Information’s new report, The Direct-To-Consumer Testing ...
(Date:1/15/2019)... ... 2019 , ... With the U.S. Congress designating January as Cervical Health Awareness Month , ... announces tips to help reduce the risk of Cervical Cancer. , Cervical cancer ... the #1 most common STD and an STI that almost half of all ...
(Date:1/10/2019)... ... 08, 2019 , ... VGI Medical was founded in 2007 based on an ... to the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems ... patented dual geometric design to limit motion of the affected spinal segment. Applying the ...
Breaking Biology Technology:
(Date:1/20/2019)... ... ... Boston-based Laboratory as a Service (LaaS) leader, Mass Innovation Labs, has changed ... expansion and service offerings for biotech and life sciences companies. , “Meeting ... more agile and adaptable than ever before. One that doubles-down on the things that ...
(Date:1/10/2019)... ... 2019 , ... When Dr. James L. Sherley, M.D., Ph.D., founder and director ... chapter to the new book Perinatal Stem Cells: Research and Therapy, he knew immediately ... debilitating secret of stem cell medicine. For more than a half-century, stem cell ...
(Date:1/8/2019)... ... January 07, 2019 , ... Sonion , ... hearing instruments and specialty earphones, and Valencell , the leading innovator in ... in canal with an embedded biometric sensor. The BiometRIC measures key vital signs ...
Breaking Biology News(10 mins):